These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21474422)

  • 1. Etanercept-induced hypoglycemia and improved glycemic control in a patient with type 2 diabetes.
    Farrokhi F; Taylor HC; McBride NM
    Endocr Pract; 2011; 17(2):306-7. PubMed ID: 21474422
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypoglycaemia after initiation of treatment with etanercept in a patient with type 2 diabetes mellitus.
    Bonilla E; Lee YY; Phillips PE; Perl A
    Ann Rheum Dis; 2007 Dec; 66(12):1688. PubMed ID: 17998221
    [No Abstract]   [Full Text] [Related]  

  • 3. Persistent hypoglycemia in a patient with diabetes taking etanercept for the treatment of psoriasis.
    Cheung D; Bryer-Ash M
    J Am Acad Dermatol; 2009 Jun; 60(6):1032-6. PubMed ID: 19217693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etanercept-induced asthma in a psoriatic patient resolving with transition to ustekinumab.
    Torres T; Vilaça S; Velho G; Selores M
    Eur J Dermatol; 2012; 22(5):696-7. PubMed ID: 22910198
    [No Abstract]   [Full Text] [Related]  

  • 5. Cutaneous vasculitis and glomerulonephritis in a patient taking the anti-TNF alpha agent etanercept for rheumatoid arthritis.
    Roux CH; Brocq O; Albert C Breuil V; Euller-Ziegler L
    Joint Bone Spine; 2004 Sep; 71(5):444-5. PubMed ID: 15474402
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe generalized exanthema due to etanercept given for severe plaque psoriasis.
    Gonzalo-Garijo MA; Pérez-Calderón R; de Argila Fernández-Durán D
    Ann Allergy Asthma Immunol; 2008 Jun; 100(6):621-2. PubMed ID: 18592833
    [No Abstract]   [Full Text] [Related]  

  • 7. Is polymyositis or dermatomyositis in patients with rheumatoid arthritis induced or unveiled by anti-tumor necrosis factor treatment?
    Nagashima T; Minota S
    Clin Rheumatol; 2010 Jul; 29(7):819-20. PubMed ID: 20405301
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of diabetes mellitus during etanercept therapy in a child with systemic-onset juvenile rheumatoid arthritis.
    Bloom BJ
    Arthritis Rheum; 2000 Nov; 43(11):2606-8. PubMed ID: 11083287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etanercept marketed for moderate, severe rheumatoid arthritis.
    Am J Health Syst Pharm; 1998 Dec; 55(24):2593. PubMed ID: 9872697
    [No Abstract]   [Full Text] [Related]  

  • 10. Survival rate of etanercept for psoriasis in real life: a multicentre observational study.
    Herrera-Acosta E; Suárez-Pérez JA; Aguilera J; Gómez-García F; Jiménez-Puya R; Guimerá F; Mendiola MV; Herrera-Ceballos E
    Eur J Dermatol; 2014; 24(5):619-20. PubMed ID: 25115194
    [No Abstract]   [Full Text] [Related]  

  • 11. Etanercept associated optic neuropathy.
    Chang V; McCurdy D; Gordon LK
    Clin Exp Ophthalmol; 2007; 35(7):680-2. PubMed ID: 17894694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful etanercept desensitization in a patient with severe injection site reactions.
    Hall J; Findeisen J
    J Clin Rheumatol; 2013 Oct; 19(7):407-8. PubMed ID: 24048103
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of psoriasis vulgaris and psoriatic arthritis with etanercept].
    Mrowietz U; Barth J; Boehncke WH; Rosenbach T; Wozel G
    J Dtsch Dermatol Ges; 2005 Jun; 3(6):470-2. PubMed ID: 15892851
    [No Abstract]   [Full Text] [Related]  

  • 14. Alopecia areata during etanercept therapy.
    Pan Y; Rao NA
    Ocul Immunol Inflamm; 2009; 17(2):127-9. PubMed ID: 19412875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Psoriasis and psoriatic rheumatism: effectiveness of etanercept for cutaneous and joint lesions].
    Paul C; Solignac M
    Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):13-5. PubMed ID: 20510165
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term efficacy of etanercept in hidradenitis suppurativa: results from an open-label phase II prospective trial.
    Pelekanou A; Kanni T; Savva A; Mouktaroudi M; Raftogiannis M; Kotsaki A; Giamarellos-Bourboulis EJ
    Exp Dermatol; 2010 Jun; 19(6):538-40. PubMed ID: 19758320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etanercept: efficacy and safety for approved indications.
    Kerensky TA; Gottlieb AB; Yaniv S; Au SC
    Expert Opin Drug Saf; 2012 Jan; 11(1):121-39. PubMed ID: 22074366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etanercept in psoriasis.
    Papp KA
    Expert Opin Pharmacother; 2004 Oct; 5(10):2139-46. PubMed ID: 15461549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etanercept: a new option in the management of RA.
    Lovell CM
    J Am Pharm Assoc (Wash); 1999; 39(3):412-4. PubMed ID: 10363471
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of etanercept on insulin secretion and insulin sensitivity in a randomized trial with psoriatic patients at risk for developing type 2 diabetes mellitus.
    Martínez-Abundis E; Reynoso-von Drateln C; Hernández-Salazar E; González-Ortiz M
    Arch Dermatol Res; 2007 Nov; 299(9):461-5. PubMed ID: 17726611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.